Working with the NCL
Input of Nanomaterials - Evaluation Criteria - Intellectual Property - Education & Training
Application Process - Assay Cascade - NCL Nanoparticles - Material Transfer Agreement

Material Transfer Agreement

The National Cancer Institute (NCI) Nanotechnology Characterization Laboratory (NCL) has been designed to investigate the use of nanoparticulate material for the advancement of cancer research. This Material Transfer Agreement (MTA) permits the exchange of materials and associated information between NCI and the party providing these materials.

Annex 2 - NCL's Material Transfer Agreement (MTA)
Annex 2 - NCL's Material Transfer Agreement (MTA)

NCL Business Plan

Learn how the NCI, NIST and FDA are collaborating to fight cancer.

Quick Guide to

Application Process

View submission procedures and evaluation criteria for NCL review of nano-materials.

Next Submission Due Date for NCL Application Materials is March 1, 2009.
View submission procedures and evaluation criteria for NCL review of nano-materials.